Deutsche Bank analyst Jan Koch downgraded bioMerieux (BMXMF) to Hold from Buy with a price target of EUR 81, down from EUR 120. The firm views the company’s profit warning as unexpected.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMXMF: